Larvol Delta - NAVAL1-An-OpenLabel-Phase-2-Trial-of-Nanatinostat-in-Combination-With-Valganciclovir-in-Patients-With-EpsteinBarr-VirusPositive-EBV-RelapsedRefractory-Lymphomas

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

http://clinicaltrials.gov/ct2/show/NCT05011058

Jan 1, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next